This application is based on the encouraging results from the Phase 3 registration clinical study GLORY-2 (NCT06164873) of mazdutide 9 mg in Chinese adults with moderate to severe obesity. The study ...
Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback